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Abstract
Background: As one of the chlorinated antifertility compounds, alpha-chlorohydrin (ACH) can inhibit glyceraldehyde-
3-phosphate dehydrogenase (G3PDH) activity in epididymal sperm and affect sperm energy metabolism, maturation 
and fertilization, eventually leading to male infertility. Further studies demonstrated that the inhibitory effect of ACH on 
G3PDH is not only confined to epididymal sperm but also to the epididymis. Moreover, little investigation on gene 
expression changes in the epididymis after ACH treatment has been conducted. Therefore, gene expression studies 
may indicate new epididymal targets related to sperm maturation and fertility through the analysis of ACH-treated 
infertile animals.
Methods: Rats were treated with ACH for ten consecutive days, and then each male rat copulated with two female rats 
in proestrus. Then sperm maturation and other fertility parameters were analyzed. Furthermore, we identified 
epididymal-specific genes that are associated with fertility between control and ACH groups using an Affymetrix Rat 
230 2.0 oligo-microarray. Finally, we performed RT-PCR analysis for several differentially expressed genes to validate the 
alteration in gene expression observed by oligonucleotide microarray.
Results: Among all the differentially expressed genes, we analyzed and screened the down-regulated genes 
associated with metabolism processes, which are considered the major targets of ACH action. Simultaneously, the 
genes that were up-regulated by chlorohydrin were detected. The genes that negatively regulate sperm maturation 
and fertility include apoptosis and immune-related genes and have not been reported previously. The overall results of 
PCR analysis for selected genes were consistent with the array data.
Conclusions: In this study, we have described the genome-wide profiles of gene expression in the epididymides of 
infertile rats induced by ACH, which could become potential epididymal specific targets for male contraception and 
infertility treatment.
Background
Although sperm are initially produced in the testes of
mammals, they are incapable of capacitation and fertil-
ization. Spermatozoa become mature and acquire fertiliz-
ing capacity during the passage through the epididymis
[1,2]. During the process of sperm maturation in the
epididymis, multiple changes occur in the sperm, includ-
ing changes in morphology, biochemistry, physiology and
the acquisition of fertilizing ability due to the interaction
of epididymal secretory proteins with the spermatozoa
[3-5]. Some processes of epididymal sperm maturation,
such as substance metabolism and the initiation of pro-
gressive motility, can be selectively interrupted, which
induces dysfunction of sperm fertilization and male infer-
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tility [6]. Additionally, disrupting epididymal sperm mat-
uration does not interfere with testicular endocrine
output and sperm production or affect testosterone gen-
eration and male libido [7,8]. Therefore, the process of
sperm maturation in the epididymis may be an advanta-
geous post-testicular target for the development of safe,
rapid and reversible male contraceptives [9].
Further studies displayed that the inhibitory effect of
A C H  o n  G 3 P D H  i s  n o t  o n l y  c o n f i n e d  t o  e p i d i d y m a l
sperm but also to the epididymis [10]. Other findings
suggested that ACH can affect epididymal function
through multiple pathways, including inhibiting andro-
gen dependent enzymes such as ATPase and AChE in the
epididymis [11], influencing some markers involved in
epididymal function such as glucosidase activity, acid and
alkaline phosphatase activity, and sialidase activity [12-
14], regulating the epididymal microenvironment such as
acidity, fluid resorption and salt metabolism [15,16], and
interfering with sugar transport, lipid metabolism and
epididymal protein secretion [17-19]. All of the above
effects on epididymal function through ACH indicate
that it may influence male fertility by interfering with the
epididymal milieu, in which the spermatozoa mature,
rather than directly affecting spermatozoa. Moreover, lit-
tle investigation on gene expression changes in the
epididymis after ACH treatment has been conducted.
Therefore, gene expression studies may indicate new
epididymal targets related to sperm maturation and fer-
tility through the analysis of ACH-treated infertile ani-
mals.
Some advances in researching epididymal-specific gene
expression and function have been achieved. Transgenic
technologies have generated temporally and spatially
restricted targeted gene disruptions, which provide
promise for our progress in understanding epididymal
function and sperm maturation [20]. Gene silencing
agents, such as RNAi, can manipulate gene expression
and have been proven to be useful for the analysis of
epididymal genes involved in sperm maturation and fer-
tility [21]. Microarray technology has been widely used
for the simultaneous examination of the expression of
multiple genes and gene families for more than a decade.
Microarray techniques are advantageous for gene expres-
sion assays because they have high sensitivity, permit
analysis with a smaller amount of cells or tissues, and
allow simultaneous analysis of a wide range of genes. In
this present study, taking advantage of an oligonucleotide
microarray, we evaluated the effects of ACH on gene
expression in the epididymis, identified new genes related
to epididymal function that possibly affect sperm matura-
tion and male fertility, and provided some novel epididy-
mal targets for male contraception and infertility
research.
Methods
Animals and treatment procedure
A d u l t  S p r a g u e - D a w l e y  r a t s  w e r e  o b t a i n e d  f r o m  S i n o -
British Sippr/BK Lab Animal Co. Ltd. (Shanghai, China),
maintained under controlled light (12L: 12D) and tem-
perature (23°C), and provided with food and water ad
libitum. Male rats (330-350 g) were randomly divided
into two groups and gavaged with 1 ml/kg of solvent
(without any ACH, control) or 10 mg/kg ACH (Sigma
Chemical Co., St. Louis, MO. FW: 110.5) (treated) sus-
pended in a 0.5% methylcellulose solution containing
0.2% Tween 20 for 10 consecutive days. Virgin female rats
(220-250 g) were used for the mating study. At sacrifice,
animals were anesthetized, and blood was collected from
the abdominal aorta for testosterone (T) and dihydrotes-
tosterone (DHT) assays; then the testes, seminal vesicles,
ventral prostates and epididymides were weighed. The
left epididymides were immediately frozen in liquid
nitrogen for RNA extraction, and the right epididymides
were used for analysis of sperm morphology and motility.
All experimental studies were approved by the Shanghai
Experimental Animal Ethics Committee and complied
with Regulations on the Care and Use of Laboratory Ani-
mals promulgated by The Ministry of Science and Tech-
nology of China.
Serumal T and DHT array
The serum levels of T and DHT in rats were detected by
an enzyme linked immunosorbent assay using a T and
DHT Elisa kit (Adlitteram diagnostic laboratories, USA)
and were analyzed with a microplate and cuvette spectro-
photometer Zenyth 200 (Anthos Inc, Austria) according
to the manufacturer's instructions.
Sperm motility and morphology analysis
Sperm samples were collected from the distal cauda of
the right epididymis and were used for computer-assisted
sperm analysis (CASA) on the HTM-IVOS, (Hamilton-
Thorne Research, Beverly, MA) using version 12 of the
Toxicology Software. Approximately 5000 cauda epididy-
mal sperm were analyzed for each treatment group (n =
8). The following kinematic parameters of motility were
determined by CASA: average path velocity (VAP), curvi-
linear velocity (VCL), straight-line velocity (VSL), ampli-
t u d e  o f  l a t e r a l  h e a d  d i s p l a c e m e n t  ( A L H ) ,  b e a t  c r o s s
frequency (BCF), linearity (LIN = VSL/VCL ×100) and
straightness (STR = VSL/VAP × 100).
As for morphological analysis, the remaining sperm
samples from the motility analysis were fixed with 10%
neutral buffered formalin. Samples were aliquoted onto
slides, and sperm were analyzed using the 10× phase con-
trast objective (Motic Group Co. Ltd., GD China).
Approximately 200 to 300 sperm per sample were ana-
lyzed, and abnormal morphological parameters were bro-Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
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ken sperm (head only, tail only, other breakages) and
angulated sperm (bent at midpiece or looped). Then, the
frequency of these abnormalities was calculated. Besides
the phase contrast objective analysis of sperm morphol-
ogy, spermatozoa from the cauda epididymis fixed with
2.5% glutaral and 1% osmic acid were also used for elec-
tron microscopic analysis (Philips CM120 electron
microscope, Eindhoven, Netherlands). In order to ana-
lyze cytoplasmic droplet retention, approximately 80 to
100 midpiece sperm flagellum trans-sections per male rat
were photographed and the number of sperm with drop-
lets was calculated.
Mating and fertility evaluation
On the last day of treatment, each male rat was caged
together with two female rats in proestrus overnight.
F e m a l e  r a t s  w e r e  e x a m i n e d  t h e  n e x t  m o r n i n g  f o r  t h e
presence of sperm in their vaginal smears; this was
defined as day 0 of gestation for sperm-positive animals.
Females were sacrificed and examined for pregnancy sta-
tus on gestation day 13, and the effect of α-chlorohydrin
treatment on fertility was verified. Finally, the following
male reproductive indices were calculated: mating index
(number of sperm positive females/number of pairings),
pregnancy index (number of pregnancies/number of
sperm positive females) and fertility index (number of
pregnancies/number of pairings).
Statistical Analysis
Data are presented as mean ± SEM. The data assessing
the serum androgen level, genital organ weight, sperm
motility and pregnancy outcome were analyzed for the
difference between the control and α-chlorohydrin treat-
ment groups by One-Way ANOVA. Reproductive indices
were analyzed with the Fisher Probability Exact test.
Probabilities of less than 0.05 were considered statistically
significant.
Total RNA preparation
The total RNA was isolated from the left epididymides
using a TRIzol reagent (Invitrogen, Carlsbad, CA) and
further purified using the RNeasy Mini Kit (Qiagen,
Valencia, CA), according to manufacturer's instructions.
The total RNA was quantitatively determined by the ratio
of absorbance at 260/280 nm, and the quality was identi-
fied with denaturing agarose gel electrophoresis.
Microarray and raw probe signal processing
Double-stranded cDNA was synthesized with the One-
cycle cDNA Synthesis Kit (Affymetrix) and purified using
the GeneChip Sample Cleanup Module (Affymetrix). The
cDNA was used as a template for biotin-labeled cRNA in
vitro transcription using the GeneChip IVT Labeling Kit
(Affymetrix). After cleanup and quantitative detection,
the purified biotinylated target cRNA was processed into
short sequences by fragmentation. The hybridization
cocktail was comprised of 15 μg of fragmented biotin-
labeled cRNA with Oligo B2 incorporated and a eukary-
otic hybridization control. Subsequently, 80 μL of hybrid-
ization cocktail was hybridized onto the test chips to
detect the cRNA integrity and confirm the validity of the
system. The 3'-5' ratio of GAPDH and actin should be no
more than 3.0. Next, RAE 230 2.0 microarrays (Affyme-
trix) were directly loaded with 200 μL of hybridization
solution and put into a Genechip Hybridization Oven 640
(Affymetrix) rotating at 60 rpm at 45°C for 16 h. After
hybridization, the arrays were washed on a Genechip Flu-
idics Station 400 (Affymetrix) and scanned using the
Genechip Scanner 3000 (Affymetrix), according to the
manufacturer's protocols. Microarray images were visu-
ally inspected for quality, and the probes with low signal
intensity and excessively noisy background were removed
before further analysis. The signal values were deter-
mined using the GeneChip Operating System 1.2 (GCOS,
Affymetrix).
For each array, all the original probe sets were normal-
ized to a mean signal intensity value of 500. The default
GCOS statistical values were used for all analyses. The
expression of transcripts on the array were considered
"present" or "absent" if their detection p-values were
lower than 0.04 or higher than 0.96 using GCOS statisti-
cal analysis.
Comparative analysis epididymal gene expression between 
two groups
The differentially expressed transcripts after chlorohy-
drin treatment were defined according to the following
criteria: (1) the expression difference between the two
groups was two-fold or more, or (2) if the change in p-
value was below 0.002, then the epididymal transcript
expression in the chlorohydrin group increased in com-
parison to the control group; if the change in p-value was
higher than 0.998, then the changing trend was consid-
ered as decreasing from the chlorohydrin group to the
control group.
Differentially expressed genes classification
The functional analysis of the differentially expressed
genes was performed by a GeneSpring GX 7.3.1 (Agilent
Technologies Inc. Santa Clara, CA), which is a powerful
visualization and analysis solution designed for use with
genomic expression data, as it can test simultaneously for
Gene Ontology, Kyoto Encyclopedia of Genes, transcrip-
tion factors (TF) and gene expression in tissues.Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
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Gene expression validation by Real-Time quantitative 
polymerase chain reaction (PCR)
The total RNA prepared for the microarray was also used
for quantitative RT-PCR. The cDNA samples for RT-PCR
analysis were synthesized with oligo-dT primers using
the Superscript III First Strand Synthesis System for RT-
PCR (Invitrogen, Carlsbad, CA) according to the manu-
facturer's instructions. The primers used in the PCR
reactions are listed in Table. 1. The total volume of 20 μL
PCR reactions was prepared by mixing 2.0 μL of cDNA
sample, 2.0 μL of 10× PCR buffer, 2.0 μL of 2.5 mM dNTP,
2.0 μL of 5 μM specific gene primer pair, 0.8 μL of 25×
SYBR Green I (Fisher Scientific Co., Pittsburgh, PA), 0.2
μL of 5 units/μL Hotstar Taq Polymerase (Qiagen, Valen-
cia, CA) and 11.0 μL of ddH2O. The real-time PCR reac-
tions were performed on a Rotor-Gene 3000 instrument
(Corbett Research, Mortlake, Australia) and included an
initial incubation at 95°C for 15 min to activate the Hot-
star Taq Polymerase. Next, 35 cycles of denaturation
(95°C, 15 sec), annealing (58°C, 20 sec) and extension
(72°C, 20 sec) were performed with the consecutive
acquisition of Sybr fluorescent signals. Finally, the stan-
dard curve was established by measuring Beta-actin rela-
tive abundance and the quantitation of targeted gene
expression was analyzed. Additionally, we also performed
routine RT-PCR with agarose gel electrophoresis analysis
for the qualitative verification of the results.
Results
Effects of ACH treatment on sperm motility
The sperm concentration did not significantly decrease in
the ACH-treated group as compared to the control group
(data not shown). However, there was a significant
decrease in the percentage of motile and progressively
motile sperm (39% and 45%, respectively) from the cauda
epididymis of treated male rats compared with untreated
animals (Figure. 1). Furthermore, ACH treatment also
caused a significant decrease in other sperm motility
parameters, including VSL, VCL, ALH, STR and LIN
(Table. 2).
Effects of ACH treatment on sperm morphology
As expected under phase-contrast microscopy observa-
tion, the number of abnormal sperm from the cauda
epididymis of treated males was higher than in the con-
trols. The percentage of tailless, headless, broken, angu-
lated and other abnormal sperm all increased
significantly with ACH treatment (Table. 3). The sperm
maturation process is associated with a series of morpho-
logical changes, including the displacement of the cyto-
plasmic droplet along the mid-piece of sperm travelling
from the caput to the cauda epididymal regions [9,22,23].
Analysis of the ultrastructure of sperm from the cauda
epididymis revealed a significant increase in the percent-
age of mid-piece sperm that were surrounded by cyto-
plasmic droplets after ACH treatment (Figure. 2).
Effects of ACH treatment on male mating and fertility
In this study, although all of the males successfully mated
with at least one virgin female in proestrus, there was a
remarkable difference in the reproduction indices
between the control and ACH treatment groups . All of
the females that mated with the untreated males were
pregnant; in contrast, there was a drastically significant
Table 2: Effect of ACH treatment on other sperm motion parameters between the two groups (mean ± S.EM.).
ACH n VAP (μm/s) VSL (μm/s) VCL (μm/s) ALH (μm) BCF (Hz) STR (%) LIN (%)
0 mg/kg 8 147.5 ± 25.0 107.8 ± 16.4 235.3 ± 49.0 15.1 ± 2.0 25.5 ± 4.8 71.5 ± 3.4 47.0 ± 5.6
10 mg/kg 8 134.6 ± 12.7 89.5 ± 9.7* 194.8 ± 16.6* 12.9 ± 1.6* 26.8 ± 2.1 60.0 ± 6.8* 37.3 ± 4.1*
*P < 0.05 versus the control group. Average path velocity (VAP), Curvilinear velocity (VCL), Straight-line velocity (VSL), Amplitude of lateral head 
displacement (ALH), Beat cross frequency (BCF), Straightness (STR), Linearity (LIN).
Table 1: The primers used for Real-Time polymerase chain reaction (PCR).
Target genes Sense (5'-3') Antisense (5'-3') Size of product (bp)
β-actin CTGGGTATGGAATCCTGT GG TCATCGTACTCCTGCTTGCTG 290
Gapds GAATCGCCATTA AAGTCCGT GGCAAAGTCATCCCAGAG C 141
Lep TCTGTGGAGTAGAGCGAGGCT TTCACCCCATTCTGAGTTTGT C 123
Atp6v1g3 TGGGCTTGGAAGGACGAG GAGACCGACCAGTACAGAATGC 234Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
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decrease in the pregnancy rate for those females paired
with the treated males (Table. 4).
Effects of ACH treatment on reproductive organ weights
There were no significant changes in the body weights
between the two groups of rats. As expected, the weight
of the testis, a T-dependent organ, was not affected in
either group; furthermore, there was no effect of treat-
ment on the weight of the epididymis, seminal vesicle or
prostate, all of which are DHT-dependent tissues (data
not shown).
Effects of ACH treatment on Serumal T and DHT
In this study, neither the serum T level nor the serum
DHT level was affected with ACH treatment (Figure. 3).
Effects of ACH treatment on rat epididymal gene 
expression
According to the analysis of gene expression along the rat
epididymis using GCOS, 17,410 and 17,031 probe sets
were detected in the control and ACH treatment groups,
respectively, and account for approximately 56.1% and
54.9%, respectively, of the whole genome, which has
31,042 probe sets. When the change in p-value was
<0.002 or >0.998, there were 90 transcripts with
enhanced expression and 79 transcripts with decreased
expression in the treatment group as compared to the
control group (Figure. 4). Next, we classified the general
functions of the down- or up-regulated epididymal genes
after chlorohydrin treatment using the GeneSpring gene
ontology (GO) analysis (Figure. 5). The genes were
involved in macromolecular metabolism and transport,
primary metabolism processes, cell metabolism, regula-
tion of biological processes, immunology regulation,
hydratase activity and oxidoreductase activity. Among all
the differentially expressed genes, we analyzed and
screened the down-regulated genes associated with glu-
cose, lipid, protein and other energy metabolism pro-
cesses, which are considered the major targets of ACH
action (Table. 5). Simultaneously, the genes that were up-
regulated by chlorohydrin were detected. The genes that
negatively regulate sperm maturation and fertility include
apoptosis and immune-related genes and have not been
reported previously (Table. 6).
RT-PCR analysis of selected gene expression
We performed RT-PCR analysis for several genes includ-
ing Gapds, Atp6v1g3, and Lep to validate the alteration in
gene expression observed by oligonucleotide microarray.
The overall results of PCR analysis for these selected
genes were consistent with the array data, although the
changes in the expression level were not equal to the
array results (Figure. 6 and Table. 7).
Discussion
In the present study, we duplicated a male rat infertility
model using ACH administration (10 mg/kg/d, po, 10
days) and evaluated changes in sperm motility and mor-
phology, mating index, fertility index and pregnancy
index. The results showed that serum androgens
remained normal in ACH-treated rats and their sexual
abilities weren't negatively affected; thus, it is considered
the best method for male contraception. We determined
that the down-regulated epididymal genes relate to sub-
stance metabolism, which affects epididymal sperm mat-
uration and is presumed to be the major antifertility
targets by ACH. Furthermore, we identified and analyzed
the epididymal up-regulated genes that are associated
with apoptosis and immune function and may be novel
sites of action by ACH and other male antifertility agents.
Figure 1 Effect of ACH treatment on sperm motility (left) and pro-
gressive motility (right). Data are represented as mean ± S.EM. * P < 
0.05 versus the control group, n = 8.
Table 3: Comparison between the ACH treated and control groups in the percentage of abnormal cauda epididymis sperm 
(mean ± S.EM.).
ACH n Headless 
(%)
Tailless (%) Angulated 
(%)
Broken (%) Other (%) Total (%)
0 mg/kg 8 0.51 ± 0.12 0.83 ± 0.15 3.23 ± 0.29 0.25 ± 0.04 0.26 ± 0.12 5.07 ± 0.83
10 mg/kg 8 4.20 ± 0.32* 5.6 ± 0.89* 6.13 ± 0.46* 1.36 ± 0.32* 0.93 ± 0.42* 18.22 ± 2.56*
*P < 0.05 versus the control groupXie et al. Reproductive Biology and Endocrinology 2010, 8:37
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Figure 2 Electron microscopic analysis of the effect of ACH treatment on sperm morphology. A: In the control, there are no mid-piece sperm 
that are surrounded by cytoplasmic droplets; B: After ACH treatment, there are some mid-piece sperm surrounded by cytoplasmic droplets (black 
arrows); C: Comparison of the percentage of sperm droplet retention between the control and ACH groups. *P < 0.05 versus the control group.Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
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ACH is well known to inhibit the activity of G3PDH,
one of the glycolytic enzymes that interferes with
epididymal sperm maturation [10,14]. In our study, the
transcript of G3PDH was remarkably down-regulated by
ACH, and some other enzymes associated with the glyco-
lytic pathway were also inhibited. The results are consis-
tent with previous studies regarding the association
between ACH and antifertility. The inhibitory effects of
ACH on G3PDH activity in vitro are thought to develop
via ACH oxidation within the tissues to form 3-chlorolac-
taldehyde [24]. This metabolite has a compatible chiral
conformation to act as an analog of the G3PDH substrate
3-phosphate glyceraldehyde [25]. Inhibition of G3PDH
activity induces an ineffective glycolytic cycle by the pres-
ence of the saccharide and results in the depletion of ATP.
Sperm motion, capacitation and fertility are repressed by
ACH due to a deficiency of ATP in the epididymal sperm
[26-28].
Our analytic results showed that the expression of
some of the ATPase transcripts, such as Atp6v1g3, was
decreased strikingly. Several previous studies suggested
that ATPases were essential for sperm motility [29-31].
The underlying mechanism is potentially that ATPases
can facilitate sperm energy production to provide sup-
port for sperm material metabolism associated with the
maturation process. Our present experiment showed that
ACH could inhibit expression of some ATPases in the
epididymis, which possibly blocks epididymal energy
metabolism and changes epididymal function and mate-
rial metabolism. Furthermore, when the secretory activ-
ity of epididymal epithelial cells is disturbed, the
epididymal microenvironment should change subse-
quently. All of the above alterations lead to dysfunction in
the sperm-egg fusion and male fertility by affecting
sperm maturation.
From our microarray results, ACH could also signifi-
cantly inhibit the expression of genes associated with
epididymal lipid metabolism, such as leptin, smgb, and
lrp5, resulting in changes in the epididymal microenvi-
ronment. Among these down-regulated genes, leptin may
reduce lipogenesis and enhance lipolysis or energy con-
sumption to control body weight. Further studies found
that the epididymides could also synthesize and secret
leptin which was considered expressed in spermatozoa
and not in epididymis. Leptin is considered an important
compound affecting sperm lipid metabolism, protein
phosphorylation and glycogen synthetase activity [32-35].
Therefore, leptin may play a role in the process of sperm
capacitation through modifying the sperm membrane
structure, protein modification and energy storage. Our
experimental oligo-microarray and RT-PCR results sug-
gested that ACH could inhibit the expression of leptin in
the epididymis, and the metabolism of spermatozoa in
the epididymis might be influenced. The inhibition of
lipid metabolism increases the retention rates of sperm
droplets, which induces abnormal changes in the sperm
membrane structure, and the inhibitory effect on protein
phosphorylation blocks local protein modification. In
addition, the retardation of glycogen synthesis induces a
disruption in the energy metabolism of epididymal sperm
and is accompanied with abnormal changes regarding
sperm motility and morphology. Carbohydrates are
essential for the sperm's ability to penetrate through the
zona pellucida and for sperm-oocyte binding. If the
sperm's storage capacity is attenuated, the sperm-oocyte
binding will be dysfunctional, and male fertility will be
decreased.
Table 4: Effect of ACH treatment on male reproductive indices (%).
ACH Copulation Index Pregnancy Index Fertility Index
0 mg/kg 87.5%(14/16) 100%(14/14) 87.5%(14/16)
10 mg/kg 81.3%(13/16) 14.3%(2/14)* 12.5%(2/16)*
*P < 0.05 versus the control group
Figure 3 Effect of ACH treatment on serum T and DHT levels. Data 
are represented as mean ± S.EM.Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
http://www.rbej.com/content/8/1/37
Page 8 of 13
Table 5: The down-regulated epididymal metabolism-related genes from the ACH treatment group compared with the 
control group.
Probe set ID GenBank NO. SLR* Gene symbol Gene 
annotations
Gene ontology
Gapdhs NM023964 -2.6 glyceraldehyde-3-
phosphate 
dehydrogenase
glyceraldehyde-3-
phosphate 
dehydrogenase 
activity
1397006_at BF401586 -5.5 Prkcb1 Protein kinase C, 
beta 1
protein kinase C 
activity, ATP 
binding
1368561_at NM033352 -1.3 Abcd2 ATP-binding 
cassette, sub-
family D (ALD),
ATPase activity, 
fatty acid 
metabolism
1383893_at AW140864 -1.0 Atp6v1g3 ATPase, ATP hydrolysis 
coupled proton 
transport
1391902_at AW527377 -2.7 Pgam2 Phosphoglycerat
e mutase 2
bisphosphoglycer
ate phosphatase 
activity
1368547_at NM130402 -1.5 Ocil osteoclast 
inhibitory lectin
sugar binding
1384837_at AI137672 -1.1 Cd69 CD69 antigen glucose 
metabolism, lipid 
metabolism, JAK-
STAT cascade, 
regulation of 
cholesterol 
absorption
1387748_at NM013076 -1.1 Lep leptin glucose 
metabolism, lipid 
metabolism, fatty 
acid catabolism, 
protein binding, 
JAK-STAT cascade
1380241_at AW435376 -3.4 Lrp5 low density 
lipoprotein 
receptor-related 
protein 5
lipid metabolism
1386964_at NM080775 -1.8 Smgb neonatal 
submandibular 
gland protein B
lipid binding
1374863_at BI283223 -1.3 RGD1562168 similar to retinoid 
binding protein 7
lipid binding
1393359_at AW534487 -2.3 Ap3b2 adaptor-related 
protein complex 
3, beta 2 subunit
intracellular 
protein transport
1398695_at BF389056 -5.4 App Amyloid beta (A4) 
precursor protein
protein binding
1368642_at NM031333 -4.4 Cdh2 cadherin 2 protein binding
1387839_at NM012646 -1.7 Cul2 Cullin 2 protein 
ubiquitinationXie et al. Reproductive Biology and Endocrinology 2010, 8:37
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1367973_at NM031530 -1.2 Ccl2 chemokine 
(C-C motif) 
ligand 2
G-protein-
coupled receptor 
binding
1370034_at NP598256 -1.2 Cdc25b cell division cycle 
25 homolog B 
(S. cerevisiae)
hydrolase activity
1384190_at BF553848 -1.0 Mapk8ip3 mitogen-
activated protein 
kinase 8 
interacting 
protein 3
serine-type 
peptidase activity
*The "SLR", which is fully spelt by "Signal log Ratio", indicates the log ratio of signal intensity in ACH treated group in relative to that in control 
group. The expressions of the genes listed above in ACH-treated group are down-regulated by 2SLR times.
Table 5: The down-regulated epididymal metabolism-related genes from the ACH treatment group compared with the 
control group. (Continued)
Table 6: The up-regulated epididymal genes in the ACH treatment group compared with the control group.
Probe set ID GenBank NO. SLR* Gene symbol Gene 
annotations
Gene ontology
1368294_at NM053907a 1.4 Dnase1l3 deoxyribonucleas
e I-like 3
DNA 
fragmentation 
during apoptosis
1379794_at AI029386a 1.0 Gzmb granzyme B Cytolysis, 
proteolysis, 
apoptosis
1387011_at NM130741a 1.0 Lcn2 lipocalin 2 apoptosis
1388202_at BI395698b 3.0 RT1-Aw2 RT1 class Ib, locus 
Aw2
antigen 
presentation, 
MHC class I 
receptor activity
1370463_x_at U50449b 2.5 RT1-CE16 RT1 class I, CE16 antigen 
presentation, 
MHC class I 
receptor activity
1374342_at BE096652b 1.8 Ly6g6c lymphocyte 
antigen 6 
complex
immune response
1388203_x_at BI395698b 1.5 RT1-A3 RT1 class I, A3 antigen 
presentation, 
endogenous 
antigen via MHC 
class I
1385551_at AW141043b 1.3 Mcpc MHC class I 
protein complex
MHC class I 
receptor activity
1398390_at AA892854b 1.0 LOC498335 Small inducible 
cytokine B13 
precursor
immune response
a apoptosis-related genes; b immune-related genes.
*The "SLR" is fully spelt by "Signal log Ratio", which indicates the log ratio of signal intensity in ACH treated group in relative to that in control 
group. The expression of the genes listed above in ACH-treated group is up-regulated by 2SLR times.Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
http://www.rbej.com/content/8/1/37
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Figure 4 Scatter plot of epididymal-expressed genes between the two groups. The yellow points represent genes that are not expressed in ei-
ther group. The blue points indicate the genes that are expressed in either of the two groups. The red points denote genes that are expressed in both 
groups. The four upper-left diagonal lines represent the fold of up-regulated gene expression, which is 2, 3, 10 and 30 times, respectively; meanwhile, 
the four lower-right diagonal lines represent the fold of down-regulated gene expression, which is 1/2, 1/3, 1/10 and 1/30, respectively.Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
http://www.rbej.com/content/8/1/37
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As an alternative nonhormonal method, epididymal
immunocontraception has become a hot topic in male
contraceptive research and involves many epididymis/
testis-specific proteins, such as Eppin (epididymal pro-
tease inhibitor) and Bin1b [36,37]. Successful immuno-
contraception would develop an effective, safe, and
reversible method for male contraception. In the present
study, we found that ACH up-regulated the expression of
some epididymal genes associated with the immune reac-
tion, such as RT1-Aw2, Ly6g6c, and LOC498335. These
genes/proteins could become potential epididymal spe-
cific targets for male immunocontraception and infertil-
ity treatment.
Conclusions
We employed ACH treatment and oligonucleotide
microarray analysis to examine the effect of ACH on gene
expression in the epididymis. We preliminarily con-
structed a genome-wide profile of gene expression in the
epididymis of rats with ACH-induced infertility, and this
analysis potentially provides some new epididymal tar-
gets for male contraception and infertility investigations.
Table 7: Analysis of gene expression data by quantitative PCR.
ACH Gapds Lep Atp6v1g3
0 mg/kg 1.0000 1.0000 1.0000
10 mg/kg 0.3031* 0.4122* 0.3734*
*Significantly different from control at 0.05 level by ANOVA test. Values from the ACH treated group are represented as a ratio relative to the 
control samples, which have a value of 1.0000.
Figure 5 The functional classification of the differentially expressed genes between the two groups.Xie et al. Reproductive Biology and Endocrinology 2010, 8:37
http://www.rbej.com/content/8/1/37
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